Items tagged with Treatment
Unknown unknowns: poverty and tuberculosis in Romania (post with simple image)
Mircea, a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB) at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted little to do with him. He was one of the many patients who doctors in Romania refer to as “social cases” According to Dr. Ionescu at the Pines, patients like Mircea are “repeat clients” with “no chance of escape.” They are people with overlapping social and economic difficulties, such as poverty, homelessness, alcohol use, lack of family support, as well as the social stigma that comes with having TB in Romania.
Advocates call for the Philippines Food and Drug Administration to register delamanid (post with simple image)
TB advocates encourage the Philippines Food and Drug Administration to approve delamanid, an important treatment option for people with multidrug-resistant TB.
Advocates call on the Indian Prime Minister to ensure availability of new TB drugs to combat drug-resistant TB (post with simple image)
Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.
Health groups call on Indian Government to urgently make life-saving TB drug available (post with simple image)
Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.
Advocates maintain pressure on the Ministry of Health to facilitate access to delamanid in Peru (post with simple image)
TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.
WHO maintains existing recommendations for the use of bedaquiline (post with simple image)
The conditional recommendation will be maintained until a new systematic review of evidence is warranted or the results of the phase III clinical trial of bedaquiline become available.
Advocates encourage the health authorities in Peru to approve the endTB study (post with simple image)
TB advocates stress the importance of the observational endTB study for expanding access to new treatments for multidrug-resistant TB in Peru.
Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval (post with simple image)
Companies and countries must take urgent action to increase access to these life-saving treatments.
Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children (post with simple image)
WHO and UNICEF issue joint statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children.
World Health Day 2017: Let’s talk about depression and TB (post with simple image)
The prevalence of mental disorders among people with TB is estimated to be between 40-70%.
Page 56 of 58 · Total posts: 0←First 55 56 57 Last→